share_log

BioXcel Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Krishnan Nandabalan(30.1%),Anesha Agarwal(0.82%), etc.

BioXcel Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Krishnan Nandabalan(30.1%),Anesha Agarwal(0.82%)等

SEC announcement ·  2023/10/19 16:48
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息